NIAID Director Anthony Fauci, Bill Gates Discuss COVID-19 Pandemic Response, Vaccines At STAT Summit

STAT: Fauci suggests he should have been ‘much more vocal’ about Covid-19 testing early in pandemic
“Anthony Fauci, the country’s top infectious disease expert, said Tuesday he should have more aggressively pushed the federal government to flood communities where the coronavirus was starting to spread with testing early in the U.S. outbreak. ‘It never became a reality because we never really had enough tests to do the tests that you had to do,’ Fauci said Tuesday at the STAT Summit, referencing the testing that needed be conducted to confirm Covid-19 infections in people who were showing symptoms of the illness…” (Joseph, 11/17).

STAT: Bill Gates worries about a ‘dysfunctional’ approach to Covid-19 vaccine distribution
“Bill Gates fears a ‘dysfunctional’ approach to distributing Covid-19 vaccines, he said Tuesday, despite an inspiring effort by biopharmaceutical companies to produce promising candidates with high measures of protection. Developing apparently effective vaccines so quickly — especially exploiting a novel approach that uses mRNA to instruct cells to make viral proteins and trigger an immune response — has been ‘fantastic,’ Gates said in conversation with Rick Berke, STAT’s co-founder and executive editor, during the 2020 STAT Summit…” (Cooney, 11/17).

Additional coverage of STAT’s conversations with Fauci and Gates is available from Bloomberg Law and Boston Globe (2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.